社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Kengyong888
IP属地：未知
+关注
帖子 · 53
帖子 · 53
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Kengyong888
Kengyong888
·
2021-09-24
Yup… can travel
非常抱歉，此主贴已删除
看
1,680
回复
3
点赞
6
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-24
$Gritstone Oncology Inc.(GRTS)$
Time to re-test $9 again ! Most Bio stocks are on the rise yesterday and with Pfizer acquisition of TRIL, this May be in play !
看
2,941
回复
评论
点赞
2
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-18
$Gritstone Oncology Inc.(GRTS)$
KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!
看
2,038
回复
评论
点赞
2
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-18
Huat !
非常抱歉，此主贴已删除
看
1,984
回复
1
点赞
5
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-14
$Gritstone Oncology Inc.(GRTS)$
Trending up from Low of $6.4…. Presentation coming up on Tuesday
看
1,749
回复
评论
点赞
2
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-11
Someone postulated Poison pill theory in another forum !
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering. BioCryst
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>
看
1,878
回复
评论
点赞
4
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-11
Short covering today !!
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering. BioCryst
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>
看
1,807
回复
评论
点赞
7
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-11
Let’s see whether they issue PR today to shedmore light !!
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering. BioCryst
BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>
看
1,925
回复
2
点赞
6
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-06
$Gritstone Oncology Inc.(GRTS)$
Heavy manipulated from $10+ down to $6.4 !
看
2,825
回复
1
点赞
1
编组 21备份 2
分享
举报
Kengyong888
Kengyong888
·
2021-08-06
$Gritstone Oncology Inc.(GRTS)$
BO may be imminent! !
看
2,102
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3586309751267683","uuid":"3586309751267683","gmtCreate":1623221122945,"gmtModify":1629340907361,"name":"Kengyong888","pinyin":"kengyong888","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":412,"tweetSize":53,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.23","exceedPercentage":"93.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"93.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":861037819,"gmtCreate":1632441661431,"gmtModify":1632725603336,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"Yup… can travel ","listText":"Yup… can travel ","text":"Yup… can travel","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/861037819","repostId":"2169955066","repostType":4,"isVote":1,"tweetType":1,"viewCount":1680,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834360631,"gmtCreate":1629772521723,"gmtModify":1631884311365,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Time to re-test $9 again ! Most Bio stocks are on the rise yesterday and with Pfizer acquisition of TRIL, this May be in play !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Time to re-test $9 again ! Most Bio stocks are on the rise yesterday and with Pfizer acquisition of TRIL, this May be in play !","text":"$Gritstone Oncology Inc.(GRTS)$Time to re-test $9 again ! Most Bio stocks are on the rise yesterday and with Pfizer acquisition of TRIL, this May be in play !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834360631","isVote":1,"tweetType":1,"viewCount":2941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833282936,"gmtCreate":1629245380325,"gmtModify":1631884311371,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!","text":"$Gritstone Oncology Inc.(GRTS)$KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/833282936","isVote":1,"tweetType":1,"viewCount":2038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833202134,"gmtCreate":1629243477028,"gmtModify":1633686356554,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"Huat !","listText":"Huat !","text":"Huat !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/833202134","repostId":"1154954467","repostType":4,"isVote":1,"tweetType":1,"viewCount":1984,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897241561,"gmtCreate":1628929542353,"gmtModify":1631884311379,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Trending up from Low of $6.4…. Presentation coming up on Tuesday","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Trending up from Low of $6.4…. Presentation coming up on Tuesday","text":"$Gritstone Oncology Inc.(GRTS)$Trending up from Low of $6.4…. Presentation coming up on Tuesday","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897241561","isVote":1,"tweetType":1,"viewCount":1749,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892526680,"gmtCreate":1628674576240,"gmtModify":1633745215310,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"Someone postulated Poison pill theory in another forum !","listText":"Someone postulated Poison pill theory in another forum !","text":"Someone postulated Poison pill theory in another forum !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892526680","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://www.laohu8.com/m/news/1172810796?lang=zh_CN&edition=full","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</p><p><blockquote>BioCryst股价在盘前交易中上涨10.49%，原因是撤回了之前的股票发行。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p><p><blockquote>BioCryst Pharmaceuticals，Inc.今天宣布，它已经撤回了公开发行的提议。凭借我们强大的资产负债表以及ORLADEYO不断增加的收入<b>®</b>（berotralstat），我们认为当前的市场状况不利于按照符合我们当前股东最佳利益的条款进行发行。我们资本充足，截至2021年6月30日，现金、现金等价物、限制性现金和投资为2.228亿美元。基于我们对收入、运营费用的预期，以及从现有信贷安排中额外获得7500万美元的选择，我们相信我们当前的现金跑道将带我们进入2023年。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-11 16:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</p><p><blockquote>BioCryst股价在盘前交易中上涨10.49%，原因是撤回了之前的股票发行。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p><p><blockquote>BioCryst Pharmaceuticals，Inc.今天宣布，它已经撤回了公开发行的提议。凭借我们强大的资产负债表以及ORLADEYO不断增加的收入<b>®</b>（berotralstat），我们认为当前的市场状况不利于按照符合我们当前股东最佳利益的条款进行发行。我们资本充足，截至2021年6月30日，现金、现金等价物、限制性现金和投资为2.228亿美元。基于我们对收入、运营费用的预期，以及从现有信贷安排中额外获得7500万美元的选择，我们相信我们当前的现金跑道将带我们进入2023年。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1,"symbols_score_info":{"BCRX":0.9}},"isVote":1,"tweetType":1,"viewCount":1878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892565988,"gmtCreate":1628673652244,"gmtModify":1633745218347,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"Short covering today !!","listText":"Short covering today !!","text":"Short covering today !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892565988","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://www.laohu8.com/m/news/1172810796?lang=zh_CN&edition=full","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</p><p><blockquote>BioCryst股价在盘前交易中上涨10.49%，原因是撤回了之前的股票发行。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p><p><blockquote>BioCryst Pharmaceuticals，Inc.今天宣布，它已经撤回了公开发行的提议。凭借我们强大的资产负债表以及ORLADEYO不断增加的收入<b>®</b>（berotralstat），我们认为当前的市场状况不利于按照符合我们当前股东最佳利益的条款进行发行。我们资本充足，截至2021年6月30日，现金、现金等价物、限制性现金和投资为2.228亿美元。基于我们对收入、运营费用的预期，以及从现有信贷安排中额外获得7500万美元的选择，我们相信我们当前的现金跑道将带我们进入2023年。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-11 16:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</p><p><blockquote>BioCryst股价在盘前交易中上涨10.49%，原因是撤回了之前的股票发行。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p><p><blockquote>BioCryst Pharmaceuticals，Inc.今天宣布，它已经撤回了公开发行的提议。凭借我们强大的资产负债表以及ORLADEYO不断增加的收入<b>®</b>（berotralstat），我们认为当前的市场状况不利于按照符合我们当前股东最佳利益的条款进行发行。我们资本充足，截至2021年6月30日，现金、现金等价物、限制性现金和投资为2.228亿美元。基于我们对收入、运营费用的预期，以及从现有信贷安排中额外获得7500万美元的选择，我们相信我们当前的现金跑道将带我们进入2023年。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1,"symbols_score_info":{"BCRX":0.9}},"isVote":1,"tweetType":1,"viewCount":1807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892562154,"gmtCreate":1628673624378,"gmtModify":1633745218693,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"Let’s see whether they issue PR today to shedmore light !!","listText":"Let’s see whether they issue PR today to shedmore light !!","text":"Let’s see whether they issue PR today to shedmore light !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/892562154","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://www.laohu8.com/m/news/1172810796?lang=zh_CN&edition=full","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</p><p><blockquote>BioCryst股价在盘前交易中上涨10.49%，原因是撤回了之前的股票发行。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p><p><blockquote>BioCryst Pharmaceuticals，Inc.今天宣布，它已经撤回了公开发行的提议。凭借我们强大的资产负债表以及ORLADEYO不断增加的收入<b>®</b>（berotralstat），我们认为当前的市场状况不利于按照符合我们当前股东最佳利益的条款进行发行。我们资本充足，截至2021年6月30日，现金、现金等价物、限制性现金和投资为2.228亿美元。基于我们对收入、运营费用的预期，以及从现有信贷安排中额外获得7500万美元的选择，我们相信我们当前的现金跑道将带我们进入2023年。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.<blockquote>由于撤回了之前的股票发行，BioCryst股价在盘前交易中上涨10.49%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-11 16:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</p><p><blockquote>BioCryst股价在盘前交易中上涨10.49%，原因是撤回了之前的股票发行。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p><p><blockquote>BioCryst Pharmaceuticals，Inc.今天宣布，它已经撤回了公开发行的提议。凭借我们强大的资产负债表以及ORLADEYO不断增加的收入<b>®</b>（berotralstat），我们认为当前的市场状况不利于按照符合我们当前股东最佳利益的条款进行发行。我们资本充足，截至2021年6月30日，现金、现金等价物、限制性现金和投资为2.228亿美元。基于我们对收入、运营费用的预期，以及从现有信贷安排中额外获得7500万美元的选择，我们相信我们当前的现金跑道将带我们进入2023年。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc. announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders. We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021. Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1,"symbols_score_info":{"BCRX":0.9}},"isVote":1,"tweetType":1,"viewCount":1925,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893352705,"gmtCreate":1628240529507,"gmtModify":1631884311387,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Heavy manipulated from $10+ down to $6.4 !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Heavy manipulated from $10+ down to $6.4 !","text":"$Gritstone Oncology Inc.(GRTS)$Heavy manipulated from $10+ down to $6.4 !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/893352705","isVote":1,"tweetType":1,"viewCount":2825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893352358,"gmtCreate":1628240462074,"gmtModify":1631884311395,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586309751267683","idStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>BO may be imminent! !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>BO may be imminent! !","text":"$Gritstone Oncology Inc.(GRTS)$BO may be imminent! !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893352358","isVote":1,"tweetType":1,"viewCount":2102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}